Next report date
Report period
H1 2024
EPS estimate
−0.05USD
Revenue estimate
496.33 MUSD
−0.09USD
−145.42 MUSD
877.99 MUSD
1.42 B
About INNOVENT BIOLOGICS INC
Sector
CEO
De Chao Yu
Headquarters
Suzhou
Website
Employees (FY)
4.87 K
Founded
2011
FIGI
BBG00PDF9N51
Innovent Biologics, Inc. is a biopharmaceutical company, which engages in the developing and commercializes drugs. It operates through the following geographical segments: The People's Republic of China (PRC), the United States of America (USA), and Indonesia. The company was founded by De Chao Yu, Kevin Chen, and Scott M. Wheelwright on April 28, 2011 and is headquartered in Suzhou, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IVBXF is 5.00 USD — it has increased by 2.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Innovent Biologics Inc. stocks are traded under the ticker IVBXF.
Innovent Biologics Inc. is going to release the next earnings report on Aug 21, 2024. Keep track of upcoming events with our Earnings Calendar.
IVBXF stock is 2.20% volatile and has beta coefficient of 1.51. Check out the list of the most volatile stocks — is Innovent Biologics Inc. there?
IVBXF earnings for the last quarter are −0.01 USD per share, whereas the estimation was −0.10 USD resulting in a 87.50% surprise. The estimated earnings for the next quarter are −0.07 USD per share. See more details about Innovent Biologics Inc. earnings.
Innovent Biologics Inc. revenue for the last quarter amounts to 372.43 M USD despite the estimated figure of 359.62 M USD. In the next quarter revenue is expected to reach 481.54 M USD.
Yes, you can track Innovent Biologics Inc. financials in yearly and quarterly reports right on TradingView.
IVBXF stock has risen by 16.82% compared to the previous week, the month change is a 2.25% rise, over the last year Innovent Biologics Inc. has showed a 3.95% increase.
IVBXF net income for the last quarter is −122.93 M USD, while the quarter before that showed −20.08 M USD of net income which accounts for −512.33% change. Track more Innovent Biologics Inc. financial stats to get the full picture.
Today Innovent Biologics Inc. has the market capitalization of 8.11 B, it has decreased by 2.22% over the last week.
No, IVBXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IVBXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Innovent Biologics Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 4.87 K employees. See our rating of the largest employees — is Innovent Biologics Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Innovent Biologics Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Innovent Biologics Inc. stock shows the buy signal. See more of Innovent Biologics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Innovent Biologics Inc. future price: according to them, IVBXF price has a max estimate of 9.81 USD and a min estimate of 4.70 USD. Read a more detailed Innovent Biologics Inc. forecast: see what analysts think of Innovent Biologics Inc. and suggest that you do with its stocks.